21 May 2009
Cell-saver application in blood salvage during orthotopic liver transplantation
R Król, J Pawlicki, J Ziaja, L CierpkaAnn Transplant 2009; 14(1): 41-41 :: ID: 880346
Abstract
Background: Increased intra-operative blood loss during orthotropic liver
transplantation (OLTx) is often observed after introduction of the OLTx
programme. Massive transfusions increase the risk of early complications after OLTx and decrease liver graft survival. The aim of the study is retrospective analysis of the blood loss during OLTx and advantages of cell-saver application in blood salvage from the operative field.
Material/Methods: 41 of 46 OLTx operations performed between 2005 and 2008 at the department were analysed. Three patients who died in early postoperative period due to non-haemorrhagic reasons and 1 patient who required re-transplantation were excluded. Blood loss was estimated by measuring the volume of blood regained from the liquid aspirated from the operative field.
Results: Mean amount of blood regained from operative field was 1922.2±922.2 ml. Its mean hematocrite was 46.14±7.31%. Mean amount of blood transfused during operation was 6.1±3.2 units. Two patients died due to overlapping massive blood loss and post-reperfusion injury. There were no severe early complications in analysed group except 3 cases of acute rejection treated successfully with steroids.
Conclusions: Cell saver allows reducing significantly the amount of transfused blood during OLTx operation, what is particularly important in the early period after introduction of the programme.
Keywords: Liver Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






